All charts and data below are with dividends reinvested. (Inflation adjustment is OFF !)
NVO total return snapshot: NVO returned −38.01% over the past year and −12.47% YTD, with dividends reinvested. Since Apr. 30, 1981, NVO is up +51,164.92% in nominal total return, or +14.84%/yr, and is currently −68.73% below its total-return high on Jun. 25, 2024.
| Thu 1981-04-30💬 to Fri 2026-06-05 |
YTD
Return |
1 Year
Return |
||||
|---|---|---|---|---|---|---|
| NVO × |
−12.47%
2026-06-05 |
−38.01%
2026-06-05 |
||||
| Novo Nordisk A/S NYSE Common Stock | ||||||
| Thu 1981-04-30💬 to Fri 2026-06-05 |
Overall
Return |
Exponential
Trendline |
||||
|---|---|---|---|---|---|---|
| NVO × |
+51,164.92%
+14.84%/yr |
+18.51%/yr
(R2=0.975) |
||||
| Novo Nordisk A/S NYSE Common Stock | ||||||
| Thu 1981-04-30💬 to Fri 2026-06-05 |
Start
Value |
End
Value |
||||
|---|---|---|---|---|---|---|
| NVO × |
$10,000.00
1981-04-30 |
$5,126,491.65
2026-06-05 |
||||
| Novo Nordisk A/S NYSE Common Stock | ||||||
| Year | NVO |
|---|---|
| 2026 (YTD) | −12.47% |
| 2025 | −39.22% |
| 2024 | −15.94% |
| 2023 | +54.84% |
| 2022 | +22.66% |
| 2021 | +63.52% |
| 2020 | +23.33% |
| 2019 | +28.70% |
| 2018 | −12.12% |
| 2017 | +54.23% |
| 2016 | −36.56% |
| 2015 | +39.39% |
| 2014 | +16.67% |
| 2013 | +15.41% |
| 2012 | +44.09% |
| 2011 | +3.91% |
| 2010 | +79.50% |
| 2009 | +26.98% |
| 2008 | −19.73% |
| 2007 | +57.38% |
| 2006 | +51.05% |
| 2005 | +5.27% |
| 2004 | +34.63% |
| 2003 | +43.96% |
| 2002 | −27.23% |
| 2001 | +14.20% |
| 2000 | +38.75% |
| 1999 | −2.01% |
| 1998 | −7.34% |
| 1997 | +55.13% |
| 1996 | +38.17% |
| 1995 | +45.42% |
| 1994 | −3.53% |
| 1993 | +12.20% |
| 1992 | −0.12% |
| 1991 | +44.64% |
| 1990 | +26.22% |
| 1989 | +30.77% |
| 1988 | +84.44% |
| 1987 | −34.20% |
| 1986 | +12.96% |
| 1985 | +25.12% |
| 1984 | −57.38% |
| 1983 | +28.35% |
| 1982 | +10.15% |
| 1981 | +24.58% |
| Thu 1981-04-30💬 to Fri 2026-06-05 |
Current
Drawdown |
Worst
Drawdown |
||||
|---|---|---|---|---|---|---|
| NVO × |
−68.73%
from 2024-06-25 peak |
−74.70%
2026-03-27 from 2024-06-25 peak |
||||
| Novo Nordisk A/S NYSE Common Stock | ||||||
| Period ending Fri 2026-06-05 |
1
Year |
2
Years |
3
Years |
5
Years |
10
Years |
|
|---|---|---|---|---|---|---|
| NVO × | −38.01% |
−67.42% −42.92%/yr |
−41.10% −16.17%/yr |
+18.16% +3.39%/yr |
+91.16% +6.69%/yr |
|
| Novo Nordisk A/S NYSE Common Stock | ||||||
